UPC - Universe Pharmaceuticals GAAP EPS of $0.08 revenue of $24.2M
- Universe Pharmaceuticals press release ( NASDAQ: UPC ): 1H GAAP EPS of $0.08.
- Revenue of $24.2M (-0.4% Y/Y).
- As of March 31, 2022, the Company had cash of $14.2 million, as compared to $8.1 million as of September 30, 2021.
For further details see:
Universe Pharmaceuticals GAAP EPS of $0.08, revenue of $24.2M